Press releases appear below, filter by date.
Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure were agreed at the Half Yearly General Meeting of the ABPI on 11 November. Further changes were agreed at a special meeting of the ABPI on 1 December.
The PMCPA has issued informal guidance on certification which examines in particular the requirements in relation to projects involving a number of companies and which reflects the changes in the 2016 ABPI Code.
The 2012 Code will come into effect on 1 January 2012 with a transitional period between 1 January 2012 and 30 April 2012. During this time no promotional material or activity will be regarded as being in breach of the Code if it fails to comply with its provisions only because of newly introduced requirements.
There are different transitional provisions for Clauses 17.2 and 23.8. Details are given in the supplementary information for those clauses.
Allergan Limited and Cephalon (UK) Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry. To highlight these breaches, both are the subject of advertisements in the medical, pharmaceutical and nursing press.
Allergan Limited, Shire Pharmaceuticals Limited, Gedeon Richter and Sanofi have breached the ABPI Code of Practice for the Pharmaceutical Industry.